abstract |
The present invention relates generally to the field of methods useful in treating tissue injury. More specifically, the present invention relates to (6S)-5-methyltetrahydrofolic acid compounds, and methods of using the (6S)-5-methyltetrahydrofolic acid compounds, to treat conditions associated with nervous system injury. |